Fibroblast growth factor 21 is associated with increased serum total antioxidant capacity and oxidized lipoproteins in humans with different stages of chronic kidney disease
Gómez Sámano Miguel Ángel, Vargas Abonce Valerie Paola, Martínez Sánchez Froylan David, Palacios Báez Lucía, Vera Zertuche Juan Mauricio, Navarro Flores María Fernanda, Morales García Mariana Guadalupe, Fonseca Correa Jorge Ignacio, Zuarth Vázquez Julia María, Vega Vega Olynka, Correa Rotter Ricardo, Rincón Pedrero Rodolfo, Morales Buenrostro Luis E, Alberú Gómez Josefina, Ramírez González Julia Berenice, Pacheco Domínguez Reyna Lizette, López Cervantes Malaquías, Mendoza de la Garza María de los Ángeles, Baeza Arias Yolanda Victoria, Espinosa Cuevas ÁngelesLópez Carrasco Guadalupe, López Estrada Angelina, Guillén Pineda Luz Elizabeth, Gómez Pérez Francisco J, Cuevas Ramos Daniel
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Fibroblast growth factor 21 is associated with increased serum total antioxidant capacity and oxidized lipoproteins in humans with different stages of chronic kidney disease'. Together they form a unique fingerprint.